The effect of IFN-β treatment on plasma levels of BDNF and IL-6 in relapsing-remitting multiple sclerosis patients

M Shajarian, F Alsahebfosoul, M Etemadifar - Neuroimmunomodulation, 2021 - karger.com
Background: In recent investigations addressing neurodegenerative diseases, especially
multiple sclerosis (MS), the roles of brain-derived neurotrophic factor (BDNF) and interleukin …
被引用次数：8 相关文章

The Effect of IFN-β Treatment on Plasma Levels of BDNF and IL-6 in Relapsing-Remitting Multiple Sclerosis Patients

M Shajarian, F Alsahebfosoul, M Etemadifar - Neuroimmunomodulation, 2021 - karger.com
Background: In recent investigations addressing neurodegenerative diseases, especially
multiple sclerosis (MS), the roles of brain-derived neurotrophic factor (BDNF) and interleukin …

The Effect of IFN-β Treatment on Plasma Levels of BDNF and IL-6 in Relapsing-Remitting Multiple Sclerosis Patients.

M Shajarian, F Alsahebfosoul… - …, 2021 - europepmc.org
Background In recent investigations addressing neurodegenerative diseases, especially
multiple sclerosis (MS), the roles of brain-derived neurotrophic factor (BDNF) and interleukin …

The Effect of IFN-β Treatment on Plasma Levels of BDNF and IL-6 in Relapsing-Remitting Multiple Sclerosis Patients.

M Shajarian, F Alsahebfosoul… - …, 2021 - search.ebscohost.com
Background: In recent investigations addressing neurodegenerative diseases, especially
multiple sclerosis (MS), the roles of brain-derived neurotrophic factor (BDNF) and interleukin …

The Effect of IFN-β Treatment on Plasma Levels of BDNF and IL-6 in Relapsing-Remitting Multiple Sclerosis Patients

M Shajarian, F Alsahebfosoul… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Background In recent investigations addressing neurodegenerative diseases, especially
multiple sclerosis (MS), the roles of brain-derived neurotrophic factor (BDNF) and interleukin …